CompoAtlas

Zipzoc

Natural health product licensed in Canada

Licence holder
Evolan Pharma AB
NPN or DIN-HM
02232448
Status
Active licence
Licence date
26 October 2007
Revision date
30 March 2022
Form
Pâte
Route of administration
Topique
Application type
DIN de transition

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Pétrolatum, Mineral oil

PopulationAgeQuantity per servingFrequency
Sous-population S/ONot specified1 Bande7 days

Uses authorised in Canada

Zinc oxide has a soothing and protective effect and has been shown to have a role in wound healing. ZIPZOC* is used for treatment of chronic leg ulcers. Where the cause is due to chronic venous insufficiency (poor circulation in the veins), ZIPZOC can be used under compression bandaging. For use by health professionals or consumers under the direction of a doctor.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 02232448

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line